BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 12189503)

  • 1. Disparity between mucosal and serum IgA and IgG in Helicobacter pylori infection.
    Schmausser B; Eck M; Greiner A; Lührs H; Vollmers HP; Müller-Hermelink HK
    Virchows Arch; 2002 Aug; 441(2):143-7. PubMed ID: 12189503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. gammadelta T cells increase with gastric mucosal interleukin (IL)-7, IL-1beta, and Helicobacter pylori urease specific immunoglobulin levels via CCR2 upregulation in Helicobacter pylori gastritis.
    Futagami S; Hiratsuka T; Suzuki K; Kusunoki M; Wada K; Miyake K; Ohashi K; Shimizu M; Takahashi H; Gudis K; Kato S; Tsukui T; Sakamoto C
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):32-40. PubMed ID: 16706809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune responses against Helicobacter pylori in gastric cancer patients and in risk groups for gastric cancer.
    Adamsson J; Lundin SB; Hansson LE; Sjövall H; Svennerholm AM
    Helicobacter; 2013 Feb; 18(1):73-82. PubMed ID: 23067268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal and systemic antibody levels against Helicobacter pylori do not parallel gastric inflammatory changes.
    Luzza F; Maletta M; Imeneo M; Marcheggiano A; Biancone L; Pallone F
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):36-9. PubMed ID: 9615262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Helicobacter pylori infection on the humoral immune response to MUC1 peptide in patients with chronic gastric diseases and gastric cancer.
    Klaamas K; Kurtenkov O; von Mensdorff-Pouilly S; Shljapnikova L; Miljukhina L; Brjalin V; Lipping A
    Immunol Invest; 2007; 36(4):371-86. PubMed ID: 17691020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucosal immune response to Helicobacter pylori and cytotoxic mechanism.
    Sugiyama T; Yabana T; Yachi A
    Scand J Gastroenterol Suppl; 1995; 208():30-2. PubMed ID: 7777802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between mucosal levels of Helicobacter pylori-specific IgA, interleukin-8 and gastric inflammation.
    Zhang QB; Etolhi G; Dawodu JB; Gemmell CG; Russell RI
    Clin Sci (Lond); 1999 Apr; 96(4):409-14. PubMed ID: 10087249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue IgA antibody against Helicobacter pylori in patients with gastroduodenal diseases: comparison with bacterial culture, serum IgG antibody, and [13C]Urea breath test.
    Matsukura N; Onda M; Tokunaga A; Kato S; Kyono S; Yamashita K
    J Clin Gastroenterol; 1995; 21 Suppl 1():S146-50. PubMed ID: 8775008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adoptive transfer of splenocytes in SCID mice implicates CD4+ T cells in apoptosis and epithelial proliferation associated with Helicobacter pylori-induced gastritis.
    Peterson RA; Hoepf T; Eaton KA
    Comp Med; 2003 Oct; 53(5):498-509. PubMed ID: 14655992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphoid aggregates in gastric biopsies: relationship to other mucosal lesions.
    Jaśkiewicz K; Kobierska G
    Arch Immunol Ther Exp (Warsz); 2000; 48(3):201-4. PubMed ID: 10912626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of B cell responses in the stomach of Helicobacter pylori- infected subjects after oral cholera vaccination.
    Mattsson A; Lönroth H; Quiding-Järbrink M; Svennerholm AM
    J Clin Invest; 1998 Jul; 102(1):51-6. PubMed ID: 9649556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased IgA antibody production in the stomach of gastric adenocarcinoma patients.
    Quiding-Järbrink M; Sundström P; Lundgren A; Hansson M; Bäckström M; Johansson C; Enarsson K; Hermansson M; Johnsson E; Svennerholm AM
    Clin Immunol; 2009 Jun; 131(3):463-71. PubMed ID: 19249247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response of IgG1 and IgG2 subclasses to Helicobacter pylori in subjects with chronic inflammation of the gastric mucosa, atrophy and gastric cancer in a country with high Helicobacter pylori infection prevalence.
    Vorobjova T; Ren Z; Dunkley M; Clancy R; Maaroos HI; Labotkin R; Kull K; Uibo R
    APMIS; 2006 May; 114(5):372-80. PubMed ID: 16725014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic humoral anti-Helicobacter pylori immune response in patients with gastric malignancies and benign gastroduodenal disease.
    Manojlovic N; Nikolic L; Pilcevic D; Josifovski J; Babic D
    Hepatogastroenterology; 2004; 51(55):282-4. PubMed ID: 15011886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti Helicobacter pylori IgG and IgA response in patients with gastric cancer and chronic gastritis.
    Manojlovic N; Babic D; Filipovic-Ljeshovic I; Pilcevic D
    Hepatogastroenterology; 2008; 55(82-83):807-13. PubMed ID: 18613460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local and systemic immune responses in humans against Helicobacter pylori antigens from homologous and heterologous strains.
    Tinnert A; Mattsson A; Bölin I; Dalenbäck J; Hamlet A; Svennerholm AM
    Microb Pathog; 1997 Nov; 23(5):285-96. PubMed ID: 9405206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum antibody positivity for distinct Helicobacter pylori antigens in benign and malignant gastroduodenal disease.
    Schumann C; Triantafilou K; Rasche FM; Möricke A; Vogt K; Triantafilou M; Hahn P; Schneider EM; Lepper PM
    Int J Med Microbiol; 2006 Aug; 296(4-5):223-8. PubMed ID: 16600680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic effects of molecularly designed antigen UREB138 for mice infected with Helicobacter pylori.
    Morihara F; Hifumi E; Yamada M; Nishizono A; Uda T
    Biotechnol Bioeng; 2008 Jul; 100(4):634-43. PubMed ID: 18306426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies.
    Camorlinga-Ponce M; Flores-Luna L; Lazcano-Ponce E; Herrero R; Bernal-Sahagún F; Abdo-Francis JM; Aguirre-García J; Muñoz N; Torres J
    Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2498-504. PubMed ID: 18768521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of the immune response to Helicobacter pylori in the development of intestinal metaplasia.
    Sugiyama T; Awakawa T; Hayashi S; Hisano K; Yabana T; Kurokawa I; Yachi A
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S89-92. PubMed ID: 7735943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.